News from SGC

Posted on Monday 27th of October 2014

SGC Toronto will hold a free workshop ‘EZH2 Inhibitors: Target Validation through Chemical Biology’, on February 9th, 2015 at the Princess Margaret Cancer Centre in Toronto, ON.

The goal of this event is to share practical knowledge gained using EZH2 inhibitors in various cellular and in vivo systems. In the spirit of sharing information, this workshop will be highly interactive. 

The workshop will feature presentations from scientists in academia and industry. Participants are encouraged to submit posters from which 3-4 will be chosen for short oral presentations. 

Posted on Wednesday 15th of October 2014
Posted on Monday 13th of October 2014
Every year, about 60 DPhil students start a life changing experience in the Nuffield Department of Medicine in Oxford.
Sarah Dixon-Clarke, born in the UK, joined the University of Oxford in 2011 after studying Biological Sciences and Biochemistry at the University of St Andrews. Sarah is affiliated with University College and works on structure-function analysis of the extended cyclin-dependent kinase family under the supervision of Dr Alex Bullock.

Posted on Thursday 2nd of October 2014

"Making pharmaceutical research more open could shave years off the time it takes to bring a new drug to market".

SGC's commitment to accelerating drug discovery is profiled by John Lorinc in the University of Toronto Magazine.

Posted on Wednesday 27th of August 2014

On Friday August 22nd, 2014, sixteen members of SGC at University of Toronto completed the ALS Ice Bucket Challenge outside the MaRS building (video here). As part of the challenge, SGC's Director, Aled Edwards nominated Takeda's General Manager Tetsu Maruyama. In a video released today, Dr Maruyama responded along with seven of his Takeda colleagues. 

Takeda has been a partner of the consortium since 2012.

In addition to completing the Ice Bucket Challenge, SGC-Toronto has raised $1,200 for ALS Canada.  

Posted on Tuesday 26th of August 2014

The Structural Genomics Consortium in Toronto hosted ChemNET's first Bootcamp for the 2013-2015 trainees. 

ChemNET is an NSERC CREATE training program that provides Chemistry graduate students and post-doctoral fellows the opportunity to gain practical medicinal and biological chemistry experience developing chemical probes for epigenetic proteins in collaboration with the pharmaceutical industry. All of ChemNET's output is open access and will be placed in the public domain with no restrictions. 

Posted on Wednesday 20th of August 2014
GC Toronto held the “Histone methyltransferases; Structure, Mechanism and Inhibition” symposium in Toronto on Thursday August 21st, 2014
Posted on Tuesday 5th of August 2014

 

Faster Cures interviews SGC Director Aled Edward on their Innovators spotlight. 

Aled Edwards: Carrying Out Open-Access Research in Structural and Chemical Biology

Posted on Friday 25th of July 2014
SGC Toronto will host ChemNET’s first Bootcamp in Medicinal Chemistry from 28th July - 22nd August 2014.
Posted on Monday 7th of July 2014

SGC Toronto will hold the “Histone methyltransferases; Structure, Mechanism and Inhibition” symposium in Toronto on Thursday August 21st, 2014. During this one-day epigenetics symposium ten renowned speakers will present their work on Protein Arginine Methyltransferases (PRMTs), Protein Lysine Methyltransferases (PKMTs) and related medicinal chemistry. This symposium is sponsored by ChemNet, an NSERC CREATE medicinal chemistry training programme in partnership with the SGC and the pharmaceutical industry.

For more details, please go to http://www.thesgc.org/symposia/toronto/MTase-2014

Pages

Subscribe to News from SGC
glqxz9283 sfy39587stf02 mnesdcuix8
sfy39587stf03